XML 21 R13.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Consolidated Balance Sheet Details | 6 Months Ended
--- | ---
Jun. 30, 2024
Consolidated Balance Sheet [Abstract] |
Consolidated Balance Sheet Details | 4. Consolidated Balance Sheet Details Property and Equipment, net Property and equipment, net consisted of the following (in thousands):
|  | June 30, |  |  | December 31, |
|  | 2024 |  |  | 2023 |
Internal-use software |  | $ | 491 |  |  | $ | 491 |
Leasehold improvements |  |  | 283 |  |  |  | — |
Laboratory equipment |  |  | 144 |  |  |  | 178 |
Furniture and fixtures |  |  | 92 |  |  |  | 137 |
Computer hardware and software |  |  | 58 |  |  |  | 58 |
Construction in progress |  |  | 36 |  |  |  | 157 |
Property and equipment, gross |  |  | 1,104 |  |  |  | 1,021 |
Less: accumulated depreciation |  |  | (342 | ) |  |  | (259 | )
Property and equipment, net |  | $ | 762 |  |  | $ | 762 |
During the three and six months ended June 30, 2024, depreciation expense was $0.1 million. During the three and six months ended June 30, 2023, depreciation expense was immaterial. Accrued Expenses Accrued expenses consisted of the following (in thousands):
|  | June 30, |  |  | December 31, |
|  | 2024 |  |  | 2023 |
Accrued research and development costs |  | $ | 1,715 |  |  | $ | 1,868 |
Accrued clinical trial costs |  |  | 4,512 |  |  |  | 4,831 |
Accrued payroll liabilities |  |  | 3,147 |  |  |  | 7,742 |
Other accrued liabilities |  |  | 1,010 |  |  |  | 984 |
Accrued related party liabilities |  |  | 166 |  |  |  | 83 |
Total accrued expenses |  | $ | 10,550 |  |  | $ | 15,508 |
On December 5, 2023, the Company committed to and implemented a reduction in force (“RIF”) and incurred one-time termination benefits associated with severance payment obligations and continued healthcare benefits for employees terminated under the RIF of $2.2 million during the year ended December 31, 2023. Accrued severance costs associated with the RIF are included in accrued expenses on the condensed consolidated balance sheets as of June 30, 2024 and December 31, 2023. A summary of accrued severance costs associated with the RIF as of June 30, 2024 is shown in the table below (in thousands):
|  | June 30, |
|  | 2024 |
Accrued severance costs as of December 31, 2023 |  | $ | 2,178 |
Reduction in estimate for continued healthcare benefits |  |  | (113 | )
Cash payments |  |  | (1,975 | )
Accrued severance costs as of June 30, 2024 |  | $ | 90 |

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Consolidated balance sheet. + References No definition available. + Details
Name: | vtyx_ConsolidatedBalanceSheetAbstract
Namespace Prefix: | vtyx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration